Decentralized Science Funding for Biotech R&D I Sebastian Brunemeier

Decentralized Science Funding for Biotech R&D - Why do researchers struggle with funding at the NIH so much and how can DAOs + Web3 help here? Are DAOs better equipt to evaluate deal flows and how to attract new talent to this space? Listen to our strategic advisor Sebastian Brunemeier, tackling all those important topics and more in this interview. We hope you enjoy it!

Feel free to ask questions in the comments below or join our Discord and let's discuss the future of #DeSci together. You can find all links below the timestamps in the description 👇🏼
_______

Timestamps:
00:00 - Struggle for researchers to get funding via the NIH
02:21 - How Web3 can be a new source of capital
06:10 - Why should researchers look to DAOs for funding instead of the NIH?
08:50 - Is a DAO better equipped to evaluate deal flow?
10:45 - How to attract new talent to this space? (Evergreen Idea)
13:27 - From the early stage to phase 3, where do you see Molecule?
15:30 - What does it mean to investors if projects fail?
18:00 - What role does VitaDAO play here?
_______

Let's connect:

Molecule - The future of medicine belongs to everyone

[nicorome]

This emerging sector of Desci is incredible! I am excited to see what is possible in the future!

[anaa]

Excellent talk by a great communicator! Interesting concept for funding...

[immortalityIMT]

It's like monopoly, instead the lots are IP.